ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
C10AX16 - InclisiranATC-DDD Version 2016. Source: WHO
C - Cardiovascular System

This group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.

C10 - Lipid Modifying Agents
 

The DDDs are based on the treatment of hypercholesterolemia.

C10A - Lipid Modifying Agents, plain

Pantethine, which is also used in the treatment of hyperlipidemi, is classified as a vitamin in A11HA.

C10AX - Other Lipid Modifying Agents

This group comprises all cholesterol and triglyceride reducers, which cannot be classified in the preceding groups.
Icosapent ethyl is classified in C10AX06 - omega-3-triglycerides incl. other esters and acids.
Sulodexide is classified in B01AB.

The DDD for evolocumab is based on dosing every second week.
The DDD for volanesorsen is based on the treatment of familial chylomicronemia syndrome.

C10AX16 - Inclisiran
StärkeAdm.RouteNote
 P 
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home